InspireMD, Inc.
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
NSPR$0.78+9.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
CONDENSED CONSOLIDATED BALANCE SHEETS
| March 31 | December 31 | |
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $12,383 | $18,916 |
| Marketable securities | 13,703 | 15,721 |
| Accounts receivable: | ||
| Trade, net | 1,580 | 1,572 |
| Other | 763 | 682 |
| Prepaid expenses | 893 | 1,060 |
| Inventory | 2,822 | 2,570 |
| TOTAL CURRENT ASSETS | 32,144 | 40,521 |
| NON-CURRENT ASSETS: | ||
| Long term deposit | 430 | 426 |
| Property, plant and equipment, net | 2,736 | 2,371 |
| Operating lease right of use assets | 2,225 | 2,360 |
| Fund in respect of employee rights upon retirement | 1,137 | 1,129 |
| TOTAL NON-CURRENT ASSETS | 6,528 | 6,286 |
| TOTAL ASSETS | $38,672 | $46,807 |
CONDENSED CONSOLIDATED BALANCE SHEETS
| March 31 | December 31 | |
|---|---|---|
| 2025 | 2024 | |
| LIABILITIES AND EQUITY | ||
| CURRENT LIABILITIES: | ||
| Accounts payable and accruals: | ||
| Trade | 1,727 | 1,254 |
| Other | 5,640 | 6,424 |
| TOTAL CURRENT LIABILITIES | 7,367 | 7,678 |
| LONG-TERM LIABILITIES- | ||
| Operating lease liabilities net of current maturities | 1,639 | 1,796 |
| Liability for employee rights upon retirement and others | 1,321 | 1,247 |
| TOTAL LONG-TERM LIABILITIES | 2,960 | 3,043 |
| TOTAL LIABILITIES | 10,327 | 10,721 |
| COMMITMENTS AND CONTINGENT LIABILITIES | - | - |
| EQUITY: | ||
| Common stock, par value $0.0001 per share; 150,000,000 shares authorized at March 31, 2025 and December 31, 2024; 29,752,661 and 26,611,033 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 3 | 3 |
| Preferred C shares, par value $0.0001 per share; 1,172,000 shares authorized at March 31, 2025 and December 31, 2024; 1,718 shares issued and outstanding at March 31, 2025 and December 31 2024 | -* | -* |
| Additional paid-in capital | 293,014 | 289,589 |
| Accumulated deficit | (264,672) | (253,506) |
| Total equity | 28,345 | 36,086 |
| Total liabilities and equity | $38,672 | $46,807 |
| * | Represents an amount less than $1 thousand |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.